Kedar, E <br/><br/>
Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide. IL-2 can facilitate or inhibit tumor growth depending on the sequence of treatment and the tumor type.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  1989 
 - 74-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/BF00199920  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Animals<br/>Carcinoma--drug therapy<br/>Cyclophosphamide--therapeutic use<br/>Cytotoxicity, Immunologic--drug effects<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Interleukin-2--therapeutic use<br/>Killer Cells, Natural--immunology<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Neoplasms, Experimental--drug therapy<br/>Receptors, Interleukin-2<br/>Sarcoma, Experimental--drug therapy<br/>Thymoma--drug therapy<br/>Thymus Neoplasms--drug therapy